Date: 23 and 24 November 2015
Venue: Larnaca Cyprus
The aim of the meeting is among other things to present and elaborate on the four relevant pathways and to discuss the integration of the relevant elements.
Pathway 1: Adverse Outcome Pathway, how to come from a qualitative description to a quantifiable AOP for mixtures
Pathway 2: Testing strategy, what are the possibilities and how are the experiments linked to key-events, overseeing the instruments available
Pathway 3: Exposure driven test approaches, what can be expected from exposure assessment and how can the first results drive the test strategy
Pathway 4: from external dose to biomarkers of effect useful for epidemiology (to set a proof of principle only)